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Although pericardial effusion after cardiac surgery is frequent and usually benign, its etiology and prognosis after cardiac transplantation are unknown. During 1 year (1985) (1986) , 12 of our current transplant population (total, 189) developed moderate or large pericardial effusions confirmed by two-dimensional echocardiography. These effusions occurred within 1 month of transplantation in 10 patients and at 3 months and 4.5 years in the other two. Pericardiocentesis was performed because of clinical evidence of increasing effusions in eight patients, with demonstrable hemodynamic compromise secondary to tamponade in five. Pericardial fluid was sterile in all but one. Endomyocardial biopsy at the time of increasing effusion revealed moderate acute rejection in five patients, mild rejection in three, and no rejection in four. All three patients with mild rejection had moderate acute rejection on subsequent biopsy performed within 7 days. In two of the four with no rejection, repeat biopsy within 5 days showed moderate acute rejection; in a third, moderate rejection was present on biopsy performed 14 days later. Legionella dumoffli was isolated from the pericardial fluid of the fourth patient, whose subsequent biopsies never showed rejection. Three of the 12 patients developed progressive ventricular dysfunction sufficiently severe to require retransplantation. One patient died suddenly 12 months after transplantation, and autopsy examination revealed severe coronary artery disease. Two died of sepsis within 3 months of transplantation. Intense inflammatory infiltrates and thickening of the pericardium and epicardium were characteristically present in explanted and autopsy hearts. The remaining six patients were fully rehabilitated with normal ventricular function at 12-20 months after transplantation. These data suggest a temporal relation between development of moderate or large pericardial effusions and allograft rejection that may involve the pericardium. The For analysis of the temporal relation of acute rejection to increasing pericardial effusion, biopsy findings before and after development of clinical signs of increasing effusion were evaluated.
Echocardiography. Two-dimensional and Mmode echocardiographic studies were obtained in all patients to detect pericardial effusion and assess left ventricular systolic function. Serial studies were obtained biweekly during the initial 6 postoperative weeks and at weekly intervals thereafter. Two observers, by consensus, graded each pericardial effusion on serial two-dimensional echocardiography as small, moderate, or large. M-mode analysis included left ventricular end-diastolic and endsystolic dimensions and calculation of shortening fraction by standard methods.4 All patients were analyzed without previous knowledge of biopsy findings.
Pericardiocentesis. Pericardiocentesis was performed from the subxiphoid approach with sterile technique. The volume and gross appearance of the pericardial fluid were recorded. Microscopic examination for organisms, red blood cells, and differen- Results of serial endomyocardial biopsies and their temporal relation to clinical evidence of increasing pericardial effusion are summarized in Table 4 . Biopsies performed 7 days before increase in effusion in patients 2-12 showed mild rejection in two patients and no evidence of rejection in all others. In our index patient, the endomyocardial biopsy 6 weeks preceding her presentation, as well as four others during the preceding 12 months, showed no rejection.
Endomyocardial biopsy performed within 24 hours of diagnosis of increasing effusion revealed moderate acute rejection in five patients, mild rejection in three, and no evidence of rejection in four. The mean rejection score was significantly higher at the time of increasing pericardial effusion compared with the previous biopsy. Despite the administra- tion of acute rejection therapy to patients showing moderate rejection, the mean rejection scores in the two subsequent biopsies remained higher compared with preeffusion scores. All five patients with biopsy evidence of moderate acute rejection were treated with intravenous methylprednisolone (3 g). Follow-up biopsy performed 7-14 days after the one performed at the time of detection of effusion showed absence of rejection in one patient, reversal of rejection in three, and continued moderate rejection in two. In one of these two, resolution of moderate rejection was achieved after a further course of methylprednisolone. In the other, a third course of methylprednisolone in addition to rabbit antithymocyte globulin was required for adequate treatment of the rejection episode.
The three patients with mild rejection on the initial biopsy had all progressed to moderate acute rejection on subsequent biopsy performed 7-14 days later. Resolution of rejection in two of them required two courses of methylprednisolone as well as rabbit antithymocyte globulin in one. In the third patient, rejection was adequately treated by one course of methylprednisolone.
Of the four patients showing no evidence of rejection at the time of increasing pericardial effusion, two had moderate acute rejection on biopsy performed within 5 days subsequently. Both required three courses of methylprednisolone for treatment of persistent rejection on the two subsequent biopsies. The third patient had mild rejection on the next biopsy, but moderate rejection on the subsequent biopsy 14 days later. The fourth patient (patient 4) was found to have pericarditis with Legionella, and all four subsequent endomyocardial biopsies showed no evidence of rejection.
Clinical Course and Autopsy Results of Patients
Three patients developed progressive decline in left ventricular function consistent with nondilated, restrictive cardiomyopathy and had symptoms sufficiently severe for retransplantation. One died of intractable heart failure before a donor heart could be found; autopsy examination revealed a thickened epicardium with a pronounced perivascular infiltrate. Examination of the endomyocardium from the right ventricle showed focal areas of mild inflammatory infiltrate. The second is currently stable in New York Heart Association functional Class III. Our index patient underwent retransplantation but died of sepsis in the early postoperative period. The explanted heart weighed 360 g without atria. The pericardium was thickened, and histologic sections contained extensive lymphocytic infiltrates. Previous reports have failed to document a strong relation between pericardial effusion and acute allograft rejection. 12 Vandenberg et al reported on 52 patients who underwent regular echocardiographic examination. These authors did not identify any single clinical variable, including acute rejection, associated with effusion. They suggest that the combination of cyclosporine therapy, preoperative diagnosis of idiopathic dilated cardiomyopathy, and acute rejection yielded a probability of 86% of having pericardial effusion after transplantation. The results of the present study therefore contrast with those of Vandenberg et al and may be explained by the different methodology used. Because the present study was prospective, we were better able to assess the temporal relation of biopsy findings to development of increasing effusion. As in the Vandenberg study, stable pericardial effusions were frequently noted in the early postoperative period, and showed little correlation with acute rejection.
Increasing pericardial effusion, however, was associated with, and often preceded, acute rejection.
In the present study, one third of the patients were studied during the initial 6 weeks after transplantation, when acute rejection is common. The high frequency of biopsies needed in the 12 patients reported and the temporal relation we observed may, therefore, be coincidental. Because increasing pericardial effusion associated with acute rejection occurred in only one (index) patient during the late postoperative period, the data indicate that increasing pericardial effusion is a rare manifestation of late acute rejection. Nevertheless, our index patient presented 4 years after transplantation, with a large pericardial effusion associated with acute rejection. Even though subsequent reaccumulation of effusion was unassociated with biopsy evidence of acute rejection, histologic findings of the explanted heart suggest that an immune process unrecognized on the many previous endomyocardial biopsies examined may have accounted for the progressive decline in ventricular function during this interval. In addition to a heavy lymphocytic infiltrate, considerable plasmacytosis was noted in the right ventricle of the explanted heart. In this patient and the two others who had autopsy examinations, the pericardium was thickened and contained a lymphocytic infiltrate.
These results provide evidence, previously unreported, in support of a noninfectious inflammatory reaction involving the pericardium that is associated with acute rejection. The absence of histologic evidence of acute rejection at the time of increasing effusion in three patients and their subsequent rapid progression to acute rejection (within 2, 5, and 7 days) may be partly related to biopsy sampling error. Experimental studies have shown that acute rejection may preferentially affect either ventricle,13 but none have indicated that the pericardium may similarly be involved. Results of the present study suggest that during acute rejection an inflammatory reaction may also occur in the epicardium and the pericardium, with rapid increase in pericardial effusion.
A recent study examined the influence of different maintenance immunosuppressive regimens on the frequency of pericardial effusion in cardiac transplant recipients.7 The highest frequency of effusion occurred in patients maintained on cyclosporine without steroids. Although the relation of acute rejection to pericardial effusion was not examined, the increased prevalence of effusion in patients not maintained on steroids indicates an immune etiology. Therefore, we believe that an increasing, as opposed to stable, pericardial effusion in transplant recipients should alert physicians to the possibility of rejection or of an immune-mediated process that may become severe enough to adversely affect ventricular function.
